This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlier, J.-P.
Right arrow Articles by Mory, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlier, J.-P.
Right arrow Articles by Mory, F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2004, p. 484-486, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.484-486.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Osteosynthesis-Associated Bone Infection Caused by a Nonproteolytic, Nontoxigenic Clostridium botulinum-Like Strain

Jean-Philippe Carlier,1* Guylène K'ouas,1 Alain Lozniewski,2 François Sirveaux,3 Philippe Cailloux,3 and Francine Mory2

Centre National de Référence des Bactéries Anaérobies et du Botulisme, Institut Pasteur, Paris,1 Laboratoire de Bactériologie, Centre Hospitalier et Universitaire,2 Clinique de Traumatologie et d'Orthopédie, Nancy, France3

Received 24 July 2003/ Returned for modification 10 September 2003/ Accepted 28 September 2003

A nonproteolytic, nontoxigenic Clostridium botulinum strain identified by conventional and molecular techniques as type B-, E-, or F-like (BEF-like) was isolated from a human postsurgical wound. All previous reports of such strains have been from environmental sources. Since toxin production is the main taxonomic denominator for C. botulinum, a new name is needed for nonproteolytic, nontoxigenic BEF-like clinical isolates.

* Corresponding author. Mailing address: Centre National de Référence des Bactéries Anaérobies et du Botulisme, Institut Pasteur, 25-28 Rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: (33) 1 40 61 34 47. Fax: (33) 1 40 61 31 23. E-mail: jcarlier{at}pasteur.fr.

Journal of Clinical Microbiology, January 2004, p. 484-486, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.484-486.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Carlier, J.-P., Manich, M., Loiez, C., Migaud, H., Courcol, R. J. (2006). First Isolation of Clostridium amygdalinum from a Patient with Chronic Osteitis.. J. Clin. Microbiol. 44: 3842-3844 [Abstract] [Full Text]  
  • Mory, F., Carlier, J.-P., Alauzet, C., Thouvenin, M., Schuhmacher, H., Lozniewski, A. (2005). Bacteremia Caused by a Metronidazole-Resistant Prevotella sp. Strain. J. Clin. Microbiol. 43: 5380-5383 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»